Literature DB >> 11422485

Angiogenesis is redundant for tumour growth in lymph node metastases.

K N Naresh1, A Y Nerurkar, A M Borges.   

Abstract

AIMS: Angiogenesis is essential for the growth of solid tumours. As the role of angiogenesis is unclear in the pathogenesis of primary lymph node (LN) tumours, we wondered whether neoangiogenesis was important in supporting and promoting the growth of tumours in LNs. METHODS AND
RESULTS: We investigated 16 cases of squamous carcinoma involving oral cavity (n=9) and larynx/pyriform fossa (n=7), all of whom had lymph node metastases. Sections of the primary tumour, uninvolved mucosa, metastatic LN and nonmetastatic LN were double-immunostained with factor VIII-related antigen and MIB-1. Proliferating blood vessels, i.e. neoangiogenesis, was identified by coexpression of factor VIII-related antigen-stained blood vessels and MIB-1 staining of the endothelial cell nuclei. Counts were performed in an area of 4 mm2. Primary tumours (127-188.7), uninvolved mucosa (54-84.5) and metastatic LNs (123.5-167) had significantly lower vessel counts than nonmetastatic LNs (194-253.9) (P=0.003; P < 0.001; P < 0.001, respectively). With regard to neoangiogenesis, primary tumours (1.7-5) had significantly higher counts than uninvolved mucosa (0-0.4), nonmetastatic LNs (0-0.4) and metastatic LNs (0.9-2.4) (P < 0.001; P < 0.001; P=0.047, respectively).
CONCLUSIONS: Our data suggest that because of the rich native vascularity of lymph nodes, neoangiogenesis is redundant for the growth of metastatic tumour.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422485     DOI: 10.1046/j.1365-2559.2001.01061.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  32 in total

Review 1.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

2.  Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases.

Authors:  Han-Sin Jeong; Dennis Jones; Shan Liao; Daniel A Wattson; Cheryl H Cui; Dan G Duda; Christopher G Willett; Rakesh K Jain; Timothy P Padera
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

3.  Evidence Showing That Tumors Can Grow Without Angiogenesis and Can Switch Between Angiogenic and Nonangiogenic Phenotypes.

Authors:  Francesco Pezzella; Kevin C Gatter
Journal:  J Natl Cancer Inst       Date:  2016-04-08       Impact factor: 13.506

Review 4.  The lymph node microenvironment and its role in the progression of metastatic cancer.

Authors:  Ethel R Pereira; Dennis Jones; Keehoon Jung; Timothy P Padera
Journal:  Semin Cell Dev Biol       Date:  2015-01-22       Impact factor: 7.727

Review 5.  Non-angiogenic tumours and their influence on cancer biology.

Authors:  Tom Donnem; Andrew R Reynolds; Elizabeth A Kuczynski; Kevin Gatter; Peter B Vermeulen; Robert S Kerbel; Adrian L Harris; Francesco Pezzella
Journal:  Nat Rev Cancer       Date:  2018-03-09       Impact factor: 60.716

Review 6.  The Lymphatic System in Disease Processes and Cancer Progression.

Authors:  Timothy P Padera; Eelco F J Meijer; Lance L Munn
Journal:  Annu Rev Biomed Eng       Date:  2016-02-05       Impact factor: 9.590

7.  Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response.

Authors:  Jan Baxa; Alena Vondráková; Táňa Matoušková; Olga Růžičková; Bernhard Schmidt; Thomas Flohr; Martin Sedlmair; Jiří Ferda
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

8.  Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes.

Authors:  Ahmed M Tawfik; A A Razek; J Matthias Kerl; N E Nour-Eldin; Ralf Bauer; Thomas J Vogl
Journal:  Eur Radiol       Date:  2013-10-02       Impact factor: 5.315

Review 9.  Models and molecular mechanisms of blood vessel co-option by cancer cells.

Authors:  Yu Zhang; Sarah Wang; Andrew C Dudley
Journal:  Angiogenesis       Date:  2019-10-18       Impact factor: 9.596

Review 10.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.